Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zivo Bioscience, Inc.ZIVO · Entity 9611 | Director · 10% owner | February 27, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zivo Bioscience, Inc.
Report date February 27, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHEP Investment, LLC | 583,615 |
Reported balance
After 2026-02-27 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-02-27 · Purchase · Acquired 1,543 · Balance 583,615 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2026 Filed Mar 3, 2026 21:06 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 1,543 | $9.72 | $14,997.96 |
DisclosureSEC source: 0001654954-26-001833 · section16.xml · nonDerivative · entry 1 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · HEP Investment, LLC Disclosed balance after: 583,615 Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 14:21 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 2,434 | $10.27 | $24,997.18 |
DisclosureSEC source: 0001654954-26-001157 · section16.xml · nonDerivative · entry 1 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · HEP Investments LLC Disclosed balance after: 582,072 Read SEC document |
| January 14, 2026 Filed Jan 27, 2026 22:09 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 1,766 | $8.49 | $14,993.34 |
DisclosureSEC source: 0001654954-26-000630 · section16.xml · nonDerivative · entry 1 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by HEP Investments LLC Disclosed balance after: 579,638 Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 23:43 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 2,777 | $9.00 | $24,993.00 |
DisclosureSEC source: 0001641073-25-000004 · primary_doc.xml · nonDerivative · entry 1 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by HEP Investments LLC Disclosed balance after: 577,872 Read SEC document |
| October 10, 2025 Filed Oct 14, 2025 22:10 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 1,659 | $12.05 | $19,990.95 |
DisclosureSEC source: 0001654954-25-011774 · section16.xml · nonDerivative · entry 1 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by HEP Investments LLC Disclosed balance after: 575,095 Read SEC document |
| October 02, 2025 Filed Oct 7, 2025 00:36 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantNonstatutory Stock Options to buy Common Stock · Derivative | 926 | $10.20 Strike: $12.03 | $9,445.20 |
DisclosureSEC source: 0001654954-25-011515 · section16.xml · derivative · entry 1 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 926 Underlying: Common Stock · 926 shares Expires 2035-10-02 F1 · price: This option was issued to the reporting person pursuant to the 2024 Equity Incentive Plan for Non-Employee Directors in lieu of retainer fees of $9,452.05. Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 01:19 UTC | Zivo Bioscience, Inc. zivo · Entity 9611 | PurchaseCommon Stock | 15,322 | $15.99 | $244,998.78 |
DisclosureSEC source: 0001641073-25-000003 · primary_doc.xml · nonDerivative · entry 1 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by HEP Investments LLC Disclosed balance after: 573,436 Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 21:04 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseWarrant for Common Stock · Derivative | 348 | $14.33 Strike: $14.33 | $4,986.84 |
DisclosureSEC source: 0001654954-25-007028 · section16.xml · derivative · entry 2 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By HEP Investments LLC Disclosed balance after: 348 Underlying: Common Stock · 348 shares Expires 2030-06-13 Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 21:04 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 3,488 | $14.33 | $49,983.04 |
DisclosureSEC source: 0001654954-25-007028 · section16.xml · nonDerivative · entry 1 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By HEP Investments LLC Disclosed balance after: 558,114 Read SEC document |
| January 22, 2025 Filed Apr 4, 2025 12:23 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 2,880 | $17.53 | $50,480.64 |
DisclosureSEC source: 0001654954-25-003907 · section16.xml · nonDerivative · entry 2 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By HEP Investments LLC Disclosed balance after: 554,626 F2 · shares: The shares were acquired in exchange for the release of certain obligations of the Company under the License Co-Development Participation Agreement. Read SEC document |
| January 22, 2025 Filed Apr 4, 2025 12:23 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 7,200 | $17.53 | $126,201.60 |
DisclosureSEC source: 0001654954-25-003907 · section16.xml · nonDerivative · entry 1 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By HEP Investments LLC Disclosed balance after: 551,746 F1 · shares: The shares were acquired in exchange for the release of certain obligations of the Company under the License Co-Development Participation Agreement. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:40 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock | 5,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-25-000107 · section16.xml · nonDerivative · entry 2 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 542,111 Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:40 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock | 5,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-25-000107 · section16.xml · nonDerivative · entry 1 YALDOO LAITH L · CIK 0001641073 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 536,371 Read SEC document |
| October 16, 2024 Filed Oct 17, 2024 23:33 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseWarrant to Purchase Common Stock · Derivative | 313 | $15.96 Strike: $15.96 | $4,994.54 |
DisclosureSEC source: 0001641073-24-000004 · primary_doc.xml · derivative · entry 2 YALDOO LAITH L · CIK 0001641073 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By entity Disclosed balance after: 313 Underlying: Common Stock · 313 shares Expires 2029-10-15 Read SEC document |
| October 16, 2024 Filed Oct 17, 2024 23:33 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 3,133 | $15.96 | $49,993.28 |
DisclosureSEC source: 0001641073-24-000004 · primary_doc.xml · nonDerivative · entry 1 YALDOO LAITH L · CIK 0001641073 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By entity Disclosed balance after: 533,424 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.